BioSpace News Archive

Assembly Biosciences, Inc., a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus and diseases associated with the microbiome, announced the appointment of Thomas J. Russo as Chief Financial Officer.

Accelerates capability for TCR library expansion of T-cell receptors (TCRs) targeting neoatigens, including in hotspots

Oakrum Pharma, LLC (“Oakrum”), in collaboration with SunGen Pharma, LLC (“SunGen”), announced today the U.S. launch and commercial shipment of a generic version of Medrol® (Methylprednisolone) in 4 mg tablets.

Walgreens and TriHealth, a comprehensive not-for-profit health system with six hospitals and 130 sites of care, announced that Walgreens will be transitioning seven of its existing company-managed Cincinnati-area Walgreens Healthcare Clinics to TriHealth.

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, reports financial results for the third quarter of 2019 and provides an update on the Company’s recent developments.

Viracta Therapeutics, Inc., a precision oncology company targeting virus-associated malignancies, today announced the closing of a Series D Preferred Stock financing.

Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced an update regarding its New Drug Application (NDA) for avapritinib for the treatment of adults with PDGFRA Exon 18 mutant GIST, regardless of prior therapy, and fourth-line GIST.

Microbion Corporation of Bozeman, MT, and Microbion Pharma Corp. of Vancouver, BC (“Microbion”) today announced results from a Phase 1b trial of its novel microbial bioenergetic inhibitior, pravibismane, in patients with moderate to severe infected diabetic foot ulcers.

Annual Award Celebrates 12 EHRs, Health Systems and Pharmacy Industry Leaders for Improving Patient Safety and Workflow Efficiency

Scout Bio, a biotechnology company focused on revolutionizing pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions, today announced the appointment of Anne Traas, DVM, as Chief Development Officer.